133 related articles for article (PubMed ID: 17135739)
1. Psoriasis therapy in real life: the need for registries.
Schmitt-Egenolf M
Dermatology; 2006; 213(4):327-30. PubMed ID: 17135739
[TBL] [Abstract][Full Text] [Related]
2. PsoReg--the Swedish registry for systemic psoriasis treatment. The registry's design and objectives.
Schmitt-Egenolf M
Dermatology; 2007; 214(2):112-7. PubMed ID: 17341858
[TBL] [Abstract][Full Text] [Related]
3. Three-year registry data on biological treatment for psoriasis: the influence of patient characteristics on treatment outcome.
Driessen RJ; Boezeman JB; van de Kerkhof PC; de Jong EM
Br J Dermatol; 2009 Mar; 160(3):670-5. PubMed ID: 19210502
[TBL] [Abstract][Full Text] [Related]
4. National registries of systemic treatment for psoriasis and the European 'Psonet' initiative.
Lecluse LL; Naldi L; Stern RS; Spuls PI
Dermatology; 2009; 218(4):347-56. PubMed ID: 19077384
[TBL] [Abstract][Full Text] [Related]
5. Infliximab for the treatment of psoriasis in Greece: 4 years of clinical experience at a single centre.
Antoniou C; Stefanaki I; Stratigos A; Moustou E; Vergou T; Stavropoulos P; Avgerinou G; Rigopoulos D; Katsambas AD
Br J Dermatol; 2010 May; 162(5):1117-23. PubMed ID: 19906069
[TBL] [Abstract][Full Text] [Related]
6. Acute coronary care in the elderly, part I: Non-ST-segment-elevation acute coronary syndromes: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology.
Alexander KP; Newby LK; Cannon CP; Armstrong PW; Gibler WB; Rich MW; Van de Werf F; White HD; Weaver WD; Naylor MD; Gore JM; Krumholz HM; Ohman EM; ;
Circulation; 2007 May; 115(19):2549-69. PubMed ID: 17502590
[TBL] [Abstract][Full Text] [Related]
7. A comparison of twice-daily calcipotriol ointment with once-daily short-contact dithranol cream therapy: quality-of-life outcomes of a randomized controlled trial of supervised treatment of psoriasis in a day-care setting.
de Korte J; van der Valk PG; Sprangers MA; Damstra RJ; Kunkeler AC; Lijnen RL; Oranje AP; de Rie MA; de Waard-van der Spek FB; Hol CW; van de Kerkhof PC
Br J Dermatol; 2008 Feb; 158(2):375-81. PubMed ID: 18067483
[TBL] [Abstract][Full Text] [Related]
8. Outcomes in randomized controlled trials in psoriasis: what has changed over the last 20 years?
Morsy H; Kamp S; Jemec GB
J Dermatolog Treat; 2007; 18(5):261-7. PubMed ID: 17917937
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and tolerability of a cosmetically acceptable coal tar solution in the treatment of moderate plaque psoriasis: a controlled comparison with calcipotriene (calcipotriol) cream.
Alora-Palli MB; Perkins AC; Van Cott A; Kimball AB
Am J Clin Dermatol; 2010; 11(4):275-83. PubMed ID: 20513160
[TBL] [Abstract][Full Text] [Related]
10. A comparison of twice-daily calcipotriol ointment with once-daily short-contact dithranol cream therapy: a randomized controlled trial of supervised treatment of psoriasis vulgaris in a day-care setting.
van de Kerkhof PC; van der Valk PG; Swinkels OQ; Kucharekova M; de Rie MA; de Vries HJ; Damstra R; Oranje AP; de Waard-van der Spek FB; van Neer P; Lijnen RL; Kunkeler AC; van Hees C; Haertlein NG; Hol CW
Br J Dermatol; 2006 Oct; 155(4):800-7. PubMed ID: 16965431
[TBL] [Abstract][Full Text] [Related]
11. Methotrexate versus traditional Chinese medicine in psoriasis: a randomized, placebo-controlled trial to determine efficacy, safety and quality of life.
Ho SG; Yeung CK; Chan HH
Clin Exp Dermatol; 2010 Oct; 35(7):717-22. PubMed ID: 19925489
[TBL] [Abstract][Full Text] [Related]
12. Improvement in quality of life with infliximab induction and maintenance therapy in patients with moderate-to-severe psoriasis: a randomized controlled trial.
Reich K; Nestle FO; Papp K; Ortonne JP; Wu Y; Bala M; Evans R; Guzzo C; Li S; Dooley LT; Griffiths CE
Br J Dermatol; 2006 Jun; 154(6):1161-8. PubMed ID: 16704649
[TBL] [Abstract][Full Text] [Related]
13. Improving clinical trial design in psoriasis: Perspectives from the global dermatology community.
van de Kerkhof P; Barker J; Griffiths CE; Menter A; Leonardi C; Young M; Kemeny L; Pincelli C; Bachelez H; Katsambas A; Ståhle M; Horn EJ; Sterry W;
J Dermatolog Treat; 2011 Aug; 22(4):187-93. PubMed ID: 20887207
[TBL] [Abstract][Full Text] [Related]
14. The impact of methodological approaches for presenting long-term clinical data on estimates of efficacy in psoriasis illustrated by three-year treatment data on infliximab.
Papoutsaki M; Talamonti M; Giunta A; Costanzo A; Ruzzetti M; Teoli M; Chimenti S
Dermatology; 2010; 221 Suppl 1():43-7. PubMed ID: 20733314
[TBL] [Abstract][Full Text] [Related]
15. Long-term efficacy of biologics in the treatment of psoriasis: what do we really know?
Alwawi EA; Krulig E; Gordon KB
Dermatol Ther; 2009; 22(5):431-40. PubMed ID: 19845720
[TBL] [Abstract][Full Text] [Related]
16. A new era in the management of psoriasis? Promises and facts.
Naldi L
Dermatology; 2005; 210(3):179-81. PubMed ID: 15785042
[TBL] [Abstract][Full Text] [Related]
17. Initial experience with routine administration of etanercept in psoriasis.
de Groot M; Appelman M; Spuls PI; de Rie MA; Bos JD
Br J Dermatol; 2006 Oct; 155(4):808-14. PubMed ID: 16965432
[TBL] [Abstract][Full Text] [Related]
18. New drugs and treatment targets in psoriasis.
Kofoed K; Skov L; Zachariae C
Acta Derm Venereol; 2015 Feb; 95(2):133-9. PubMed ID: 25111317
[TBL] [Abstract][Full Text] [Related]
19. Retinoid therapy for psoriasis.
Yamauchi PS; Rizk D; Lowe NJ
Dermatol Clin; 2004 Oct; 22(4):467-76, x. PubMed ID: 15450342
[TBL] [Abstract][Full Text] [Related]
20. Management of psoriasis with calcipotriol used as monotherapy.
Ramsay CA
J Am Acad Dermatol; 1997 Sep; 37(3 Pt 2):S53-4. PubMed ID: 9344185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
